| Product Code: ETC6750549 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Pharmacogenetic Testing Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 China Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 China Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 China Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 China Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 China Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 China Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 China Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 China Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 China Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 China Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on personalized medicine and precision healthcare in China |
4.2.2 Government initiatives to promote pharmacogenetic testing for better patient outcomes |
4.2.3 Rising prevalence of chronic diseases requiring personalized treatment approaches |
4.3 Market Restraints |
4.3.1 Lack of awareness and understanding among healthcare professionals and patients about pharmacogenetic testing |
4.3.2 High initial costs associated with setting up pharmacogenetic testing facilities and infrastructure |
5 China Pharmacogenetic Testing Market Trends |
6 China Pharmacogenetic Testing Market, By Types |
6.1 China Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 China Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 China Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 China Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 China Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 China Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 China Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 China Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 China Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 China Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 China Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 China Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 China Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 China Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 China Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 China Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 China Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 China Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 China Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 China Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 China Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 China Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 China Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 China Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 China Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 China Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 China Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 China Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 China Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 China Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 China Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 China Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 China Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 China Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 China Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 China Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 China Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 China Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 China Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 China Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 China Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 China Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 China Pharmacogenetic Testing Market Export to Major Countries |
7.2 China Pharmacogenetic Testing Market Imports from Major Countries |
8 China Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Number of healthcare institutions offering pharmacogenetic testing services in China |
8.2 Adoption rate of pharmacogenetic testing by healthcare providers and patients |
8.3 Number of research studies and clinical trials incorporating pharmacogenetic testing in China |
9 China Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 China Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 China Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 China Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 China Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 China Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 China Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 China Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 China Pharmacogenetic Testing Market - Competitive Landscape |
10.1 China Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 China Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here